Feasibility Study of Virtual Sail 3D in Cognitive Functions
Recruiting now · Not applicable
Conditions studied: Mild Cognitive Impairment
In brief
This research project will assess the feasibility and preliminary effectiveness of a 6-week intervention to improve cognitive functions using the 3D immersive virtual reality software "CEREBRUM" with virtual sailing scenarios among elderly with mild cognitive impairment. CEREBRUM, developed by PRoMIND in association with IDEGO, is the first European tool for enhancing cognitive functions via 3D immersive virtual reality in psychosocial disabilities. Previous studies have shown its effectiveness in improving cognitive functions and well-being in people with bipolar disorders. The software includes modules for memory, learning, cognitive estimations, attention, working memory, and executive functions. For this study, the software was developed with sailing virtual scenarios to make it more enjoyable and engaging, as well as to train other cognitive functions such as motor skills and language abilities among people with disabilities.
Key facts
- Study ID
- NCT06579378
- Run by
- University of Cagliari
- People needed
- 40
- Starts
- 2024-05-01
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2024-08-30
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age: 65 years or older
- Sex: all
- Living independently,
- Without conditions that would prevent them from participating in the activities of the experimental intervention "VSail 3D,"
- Without severe issues with autonomous mobility
- With Mild Cognitive Impairment (MCI) according to Addenbrooke's Cognitive Examination for cognitive functions (ACE-R), which also includes the Mini-Mental State Examination (MMSE), with the following ranges: ACE = 66.93-79.86 and/or MMSE = 21-25.
- Signing the informed consent
You may not qualify if…
- severe cardiovascular conditions
- severe issues with autonomous mobility
- severe metabolic disorders not pharmacologically compensated
- severe neurological conditions that prevent from participating in the experimental protocol, such as a stroke within the past 2 years, Parkinson's disease, epilepsy, or dementia (Alzheimer's, vascular, etc.)
- severe ongoing bronchopulmonary disorders
- severe ongoing renal disorders
- glaucoma, retinal detachment, or other serious vision conditions that do not allow the safe use of 3D virtual reality technology
- active malignant neoplasm that do not allow the hinders participation in the intervention.
Where it is running
- University Hospital of Cagliari — Cagliari, CA, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.